Healthcare's Next Competitive Edge Won't Be Access. It Will Be Coordination.
Access has stopped being a differentiator. Pharmacy consultations, NHS 111, urgent treatment centres and a widening range of digital front doors mean most patients can reach a healthcare professional faster than at any point in recent memory. That is a genuine achievement, and it is also, strategically, a problem. When every organisation can offer fast access, fast access stops being an advantage. It becomes the baseline everyone is measured against.
The organisations pulling ahead are not the ones with the shortest queue. They are the ones whose systems talk to each other once a patient is inside them. A pharmacist who can see relevant history, a Telehealth consultation that carries context from the previous contact, a care plan that updates automatically rather than being re-explained at every touchpoint - none of that shows up on a waiting-time dashboard, yet it is precisely what determines whether fast access converts into good outcomes or simply into more, faster, disconnected contacts.
This is a shift healthcare leaders would do well to name explicitly. For years, investment cases have been built around expanding capacity and shortening wait times. Boards understand that argument and fund it readily. Coordination is a harder sell internally: it rarely produces a headline metric, the benefits accrue gradually, and responsibility for it sits awkwardly between clinical, operational and digital teams. That is exactly why it is becoming the differentiator. Advantages that are hard to build are, by definition, hard to copy.
Digital health's contribution here goes beyond adding capacity. Telehealth, embedded properly, is what allows a patient's journey to remain coherent across multiple providers and settings - turning separate contacts into a single continuous relationship rather than a series of disconnected transactions. Healthcare innovation that only adds channels widens the front door. Healthcare innovation that connects those channels is what compounds.
For healthcare leaders benchmarking against competitors or partner organisations, the useful question is no longer "how quickly can a patient be seen?" Most providers can now answer that similarly well. The sharper question is what happens in the six months after that first contact, and how visible that journey is to everyone involved in it. Patient access got organisations to parity. Coordination is what will separate them from it.